Stage IIIC transitional cell carcinoma and serous carcinoma of the ovary have similar outcomes when treated with platinum-based chemotherapy

BOYRAZ, GÖKHAN; BAŞARAN, DERMAN; SALMAN, MEHMET; ÖZGÜL, NEJAT; YÜCE, KUNTER

doi:10.4274/jtgga.2016.0190

Stage IIIC transitional cell carcinoma and serous carcinoma of the ovary have similar outcomes when treated with platinum-based chemotherapy

BOYRAZ G., BAŞARAN D., SALMAN M. C., ÖZGÜL N., YÜCE K.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, cilt.18, sa.1, ss.33-37, 2017 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 1
Basım Tarihi: 2017
Doi Numarası: 10.4274/jtgga.2016.0190
Dergi Adı: JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.33-37
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Previous studies reported better outcomes for transitional cell carcinoma (TCC) of the ovary when compared with more common histologic types such as serous epithelial ovarian cancers (EOCs). The aim of this study was to compare the survival outcomes of platinum-based chemotherapy in patients with stage IIIC TCCs and serous EOCs.